Loading...
•
Mar 30, 2024
Thermo Fisher Q1 2024 Earnings Report
Thermo Fisher Scientific reported strong financial results driven by its proven growth strategy and the impact of its PPI Business System.
Key Takeaways
Thermo Fisher Scientific reported a revenue decline of 3% to $10.34 billion. GAAP diluted EPS increased 4% to $3.46, and adjusted EPS increased 2% to $5.11. The company is raising its full year revenue and adjusted EPS guidance to reflect stronger operational performance.
First quarter revenue was $10.34 billion.
First quarter GAAP diluted earnings per share (EPS) increased 4% to $3.46.
First quarter adjusted EPS increased 2% to $5.11.
Active quarter of capital deployment, repurchasing $3.0 billion of stock and increasing our dividend by 11 percent.
Revenue by Segment
Forward Guidance
Thermo Fisher is raising its full year revenue and adjusted EPS guidance to reflect stronger operational performance. The company is raising its revenue guidance to a new range of $42.3 to $43.3 billion versus its previous guidance of $42.1 to $43.3 billion. The company is raising its adjusted EPS guidance to a new range of $21.14 to $22.02 versus its previous guidance of $20.95 to $22.00.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...